Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure;Solução salina hipertônica para prevenção de insuficiência renal em pacientes com insuficiência cardíaca descompensada e hiponatremia

Arquivos Brasileiros de Cardiologia

Volumn 89, Issue 4, 2007, Pages 251-255

  Issa, Victor Sarli ^a,b   Bacal, Fernando ^a   Mangini, Sandrigo ^a   Carneiro, Rodrigo Moreno Dias ^a   Azevedo, Cristiano Humberto Naves De Freitas ^a   Chizzola, Paulo Roberto ^a   Ferreira, Silvia Moreira Ayub ^a   Bocchi, Edimar Alcides ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Heart failure; Hypertonic solutions; Hyponatremia; Renal insufficiency

Indexed keywords

CREATININE; DOBUTAMINE; FUROSEMIDE; HYDRALAZINE; NITRATE; SODIUM; SODIUM CHLORIDE; SPIRONOLACTONE; UREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART FAILURE; HUMAN; HYPOKALEMIA; HYPONATREMIA; KIDNEY FAILURE; LABORATORY TEST; MALE; TREATMENT DURATION; URINE VOLUME; WEIGHT REDUCTION;

EID: 37349061375     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sales AL, Villacorta H, Reis L, Mesquita ET. Anemia como fator prognóstico em uma população hospitalizada por insuficiência cardíaca descompensada. Arq Bras Cardiol. 2005; 3 (84): 237-40.
2. Rassi S, Barretto ACP, Porto CC, Pereira CR, Calaça BW, Rassi D. Sobrevida e fatores prognósticos na insuficiência cardíaca sistólica com início recente dos sintomas. Arq Bras Cardiol. 2005; 4 (84): 309-13.
3. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006; 296: 2217-26.
4. Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003; 41: 1797-804.
5. Dries D, Exner D, Domanski M, Greenberg B, Stevenson L. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000; 35: 681-9.
6. Schrier RW. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol. 2006;47:1-8.
7. Cleland JG, Freemantle N, Coletta AP, Clark AL. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail. 2006; 8 (1): 105-10.
8. Dahle TG, Blake D, Ali SS, Olinger CC, Bunte MC, Boyle AJ. Large volume ultrafiltration for acute decompensated heart failure using standard peripheral intravenous catheters. J Card Fail. 2006; 12 (5): 349-52.
9. Gheorghiade M, Gattis WA, O'Connor CM, Adams KF, Elkayam U, Barbagelata A, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA. 2004; 291 (16): 1963-71.
10. Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, et al. ADHERE Scientific Advisory Committee and Investigators; ADHERE Study Group. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol. 2005; 46 (1): 65-7.
11. Fellippe JJ de, Timoner J, Velasco IT, Lopes OU, Rocha e Silva M. Treatment of refractory hypovolaemic shock by 7.5% sodium chloride injections. Lancet. 1980; ii: 1002-4.
12. Paterna S, Di Pasquale P, Parrinello G, Fornaciari E, Di Gaudio F, Fasullo S, et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. J Am Coll Cardiol. 2005; 45: 1997-2003.
13. Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J. 2003; 145: 459-66.
14. Paterna S, Di Pasquale P, Parrinello G, Amato P, Cardinale A, Follone G, et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. Eur J Heart Fail. 2000; 2: 305-13.
15. Bocchi EA, Vilas-Boas F, Perrone S, Caamano AG, Clausell N, Moreira M da C, et al. I Latin American Guidelines for the Assessment and Management of Decompensated Heart Failure. Arq Bras Cardiol. 2005; 85 (supl 3): 49-94; 1-48.
16. Gazitua S, Scott JB, Chou CC, Haddy FJ. Effect of osmolarity on canine renal vascular resistance. Am J Physiol. 1969; 217: 1216-23.
17. Rocha e Silva M, Velasco IT, Nogueira da Silva RI, Oliveira MA, Negraes GA, Oliveira MA. Hyperosmotic sodium salts reverse severe hemorrhagic shock: other solutes do not. Am J Physiol. 1987; 253: H751-H762.
18. Rocha-e-Silva M, Figueiredo LFP. Small volume hypertonic resuscitation of circulatory shock. Clinics. 2005; 60 (2): 159-72.
19. Kien ND, Kramer GC, White DA. Acute hypotension caused by rapid saline infusion in anesthetized dogs. Anesth Analg. 1991; 73: 597-602.
20. Boldt J, Zickmann B, Ballesteros M, Herold C, Dapper F, Hempelmann G. Cardiorespiratory responses to hypertonic saline solution in cardiac operations. Ann Thorac Surg. 1991; 51: 610-5.
21. Oliveira SA, Bueno RM, Souza JM, Senra DF, Rocha e Silva M. Effects of hypertonic saline dextran on the postoperative evolution of Jehovah's Witness patients submitted to cardiac surgery with cardiopulmonary bypass. Shock. 1995; 3: 391-4.
22. Ramires JAF, Serrano CV, César LAM, Velasco IT, Rocha e Silva Jr M, Pileggi F. Acute hemodynamic effects of hypertonic (7.5%) saline infusion in patients with cardiogenic shock due to right ventricular infarction. Circ Shock. 1992; 37 (3): 220-5.